Spine Care Technologies Inc. Announces Engagement Of Merchant Banking Firm Aleutian Capital Partners

By Author: 1888pressrelease
Total Articles: 362
Comment this article

(1888PressRelease) Spine Care Technologies has teamed up with Aleutian Capital Partners for strategic planning and financial advisory services.

New York, NY - Spine Care Technologies Inc. ("SCT" or "the Company"), the non-invasive spine care technologies industry innovator, today announced that it has retained Aleutian Capital Partners (“Aleutian”), a boutique merchant banking and investment firm affiliated with Bradley, Woods & Co. Ltd., to provide strategic corporate planning and financial advisory services.

Spine Care Technologies President & Chief Executive Officer, Roland Kiser stated, "The Company is very pleased to have retained a financial advisory firm of Aleutian’s stature to assist the company with important strategic decisions. After extensive meetings with Aleutian, management is confident that it has made an excellent decision that could materially benefit shareholders." Kiser stated further that “Aleutian’s understanding of our current momentum, combined with the ongoing next generation product development efforts, made Aleutian stand-out during the selection process.”

Lee ...
... Black, Managing Director at Aleutian Capital and a registered representative of Bradley Woods, added, "We are very pleased to bring Spine Care Technologies Inc. into our client roster. The combination of a seasoned management team with a clear vision, exciting growth prospects involving next generation product developments, a large market opportunity and a strong IP portfolio gives us confidence in the future of the Company. The Company appears to have a unique technology, a strong patent portfolio and many current and prospective partnerships. We are looking forward to assisting with strategic planning, developing strategic partnerships, and advising Spine Care Technologies moving forward.

About Spine Care Technologies Inc.:
Spine Care Technologies is a medical technology equipment developer & distributor whose flagship product (Extentrac® Elite) has earned long-standing worldwide acclaim and recognition at pain management clinics and rehabilitation hospitals. The firm’s current and future products provide relief for people who suffer from the disabling effects of acute and chronic back pain. For more information please visit: spinecaretechnologies.com

Currently available in over 15 countries, the FDA-cleared Extentrac® Elite has a 20-year track record of effectiveness and safety in delivering non-surgical, drug-free, disc and spine care treatments. Health professionals worldwide have confirmed excellent clinical outcomes in the management of low back pain in both private and hospital rehabilitation facilities using Extentrac®.

About Aleutian Capital Partners:
Aleutian Capital Partners is a boutique New York-based merchant bank serving sellers and buyers of companies throughout North and South America, Asia and Europe. Aleutian provides particular expertise in the healthcare, technology, e-commerce, aviation, aerospace, telecom, energy and industrial manufacturing industries. Services include merger and acquisition advisory, raising growth capital through Bradley Woods, valuations and recapitalizations. “Aleutian” is a service mark of Aleutian Capital Partners, LLC. All securities are offered through Bradley Woods & Co. Ltd., member, FINRA and SIPC. Aleutian Capital Partners, LLC and Bradley Woods & Co. Ltd. are independent entities. Officers of Aleutian Capital Partners are licensed registered representatives of Bradley Woods & Co. Ltd.. For more information please visit: aleutiancapital.com